Fundz

Remedy Robotics raises $62 million in Series B funding, led by DCVC, to advance its AI-enabled endovascular robotic platform for cardiovascular care.

PRIVATENov 16, 2026

Amount Raised

$62 Million

Round Type

Series B

San FranciscoManufacturingBiotechnologyHealth CareMedicalMedical DeviceRoboticsMechanical Or Industrial Engineering

Investors

Build CHostplusSkip CapitalUC InvestmentsDcvc

Description

Remedy Robotics, Inc. announced the closure of $62 million in Series B funding to enhance its AI-enabled robotic systems for cardiovascular care. The funds will support clinical trials, FDA approval efforts, and clinical deployment of their robotic platform. New investors include UC Investments, Skip Capital, and Hostplus, along with existing backers

Quick answer

Remedy Robotics raised $62 Million in a Series B round, dated November 16, 2026. Investors: Build C, Hostplus, Skip Capital, UC Investments and Dcvc. Remedy Robotics is based in San Francisco, California, United States.

How much did Remedy Robotics raise?
Remedy Robotics raised $62 Million in a Series B round on November 16, 2026.
Who invested in Remedy Robotics?
Build C, Hostplus, Skip Capital, UC Investments and Dcvc are named as investors in this round.
What does Remedy Robotics do?
Remedy Robotics is a leading medical technology company specializing in innovative robotic solutions for cardiovascular interventions.
Where is Remedy Robotics based and how big is it?
Remedy Robotics is based in San Francisco, California, United States. Fundz records about 22 employees.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Remedy Robotics that raised within 45 days of this round, from Fundz verified event records.

  • Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
  • Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
  • Total Joint Orthopedics raised $11M (Debt Financing) on October 21, 2026.
  • Nami Surgical raised $4.5M (Series A) on October 13, 2026.
  • Scarlet raised $50M (Series B) on October 12, 2026.
  • Raywatt raised $9.9M (Series B) on November 16, 2026.

Who to call at Remedy Robotics, and when

A new round usually means Remedy Robotics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Remedy Robotics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Remedy Robotics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Remedy Robotics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Remedy Robotics

Location

340 Kansas St

San Francisco, California, United States

About

Remedy Robotics is a leading medical technology company specializing in innovative robotic solutions for cardiovascular interventions. The company is developing the world's first remotely operated robot for such procedures. Remedy aims to enhance the quality of care in stroke management through advanced technology. Their commitment to transforming healthcare makes them a key player in the medical robotics field.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Remedy Robotics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Remedy Robotics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Remedy Robotics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.